803 related articles for article (PubMed ID: 22288464)
21. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.
Kozhakhmetova A; Wyatt RC; Caygill C; Williams C; Long AE; Chandler K; Aitken RJ; Wenzlau JM; Davidson HW; Gillespie KM; Williams AJK
Clin Exp Immunol; 2018 Jun; 192(3):251-258. PubMed ID: 29431870
[TBL] [Abstract][Full Text] [Related]
22. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM).
Karavanaki K; Kakleas K; Paschali E; Kefalas N; Konstantopoulos I; Petrou V; Kanariou M; Karayianni C
Horm Res; 2009; 71(4):201-6. PubMed ID: 19258711
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies Targeting Intracellular and Extracellular Proteins in Autoimmunity.
Burbelo PD; Iadarola MJ; Keller JM; Warner BM
Front Immunol; 2021; 12():548469. PubMed ID: 33763057
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq.
Vazquez SE; Ferré EM; Scheel DW; Sunshine S; Miao B; Mandel-Brehm C; Quandt Z; Chan AY; Cheng M; German M; Lionakis M; DeRisi JL; Anderson MS
Elife; 2020 May; 9():. PubMed ID: 32410729
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin variable gene analysis of human autoantibodies reveals antigen-driven immune response to glutamate decarboxylase in type 1 diabetes mellitus.
Richter W; Jury KM; Loeffler D; Manfras BJ; Eiermann TH; Boehm BO
Eur J Immunol; 1995 Jun; 25(6):1703-12. PubMed ID: 7614998
[TBL] [Abstract][Full Text] [Related]
26. Experiments by nature: lessons on type 1 diabetes.
Battaglia M
Tissue Antigens; 2014 Jan; 83(1):1-9. PubMed ID: 24355002
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
28. Seasonality of month of birth differs between type 1 diabetes patients with pronounced beta-cell autoimmunity and individuals with lesser or no beta-cell autoimmunity.
Lewy H; Hampe CS; Kordonouri O; Haberland H; Landin-Olsson M; Torn C; Laron Z
Pediatr Diabetes; 2008 Feb; 9(1):46-52. PubMed ID: 18036133
[TBL] [Abstract][Full Text] [Related]
29. Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network.
Weathington NM; Blalock JE
Expert Rev Vaccines; 2003 Feb; 2(1):61-73. PubMed ID: 12901598
[TBL] [Abstract][Full Text] [Related]
30. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
Yoon JW; Jun HS
Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.
Skyler JS; Pugliese A
Diabetes Technol Ther; 2013 Jun; 15 Suppl 2(Suppl 2):S2-13-S2-20. PubMed ID: 23786294
[TBL] [Abstract][Full Text] [Related]
32. B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response.
Routsias JG; Tzioufas AG
J Autoimmun; 2010 Nov; 35(3):256-64. PubMed ID: 20643529
[TBL] [Abstract][Full Text] [Related]
33. T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.
Mallone R; Brezar V; Boitard C
Clin Dev Immunol; 2011; 2011():513210. PubMed ID: 21785617
[TBL] [Abstract][Full Text] [Related]
34. Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse.
Wang X; Zhang A; Liu Y; Chen S; Feng Z; Shang W; Maziarz M; Radtke J; Hampe CS
PLoS One; 2012; 7(2):e32515. PubMed ID: 22384267
[TBL] [Abstract][Full Text] [Related]
35. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.
Brezar V; Carel JC; Boitard C; Mallone R
Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723
[TBL] [Abstract][Full Text] [Related]
36. Autoantigen complementarity and its contributions to hallmarks of autoimmune disease.
Pendergraft WF; Badhwar AK; Preston GA
J Theor Biol; 2015 Jun; 375():88-94. PubMed ID: 25526886
[TBL] [Abstract][Full Text] [Related]
37. Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance.
James EA; Pietropaolo M; Mamula MJ
Diabetes; 2018 Jun; 67(6):1035-1042. PubMed ID: 29784651
[TBL] [Abstract][Full Text] [Related]
38. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
[TBL] [Abstract][Full Text] [Related]
39. Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets.
Rodriguez-Calvo T; Johnson JD; Overbergh L; Dunne JL
Front Immunol; 2021; 12():667989. PubMed ID: 33953728
[TBL] [Abstract][Full Text] [Related]
40. Anti-idiotypic T cells in early stages of myasthenia gravis: increase in the number and prevalence correlated to clinical improvement in patients.
Yi Q; Pirskanen R; Lefvert AK
Scand J Immunol; 1996 Dec; 44(6):630-7. PubMed ID: 8972746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
